| MeSH term | MeSH ID | Detail |
|---|---|---|
| IgG Deficiency | D017099 | 1 associated lipids |
| Deltaretrovirus Infections | D006800 | 1 associated lipids |
| Dendritic Cell Sarcoma, Interdigitating | D054739 | 1 associated lipids |
| Polymyositis | D017285 | 1 associated lipids |
| Scorpion Stings | D065008 | 1 associated lipids |
| Rotavirus Infections | D012400 | 1 associated lipids |
| Netherton Syndrome | D056770 | 1 associated lipids |
| Pseudohypoaldosteronism | D011546 | 1 associated lipids |
| Arm Injuries | D001134 | 1 associated lipids |
| Intussusception | D007443 | 1 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mott JL et al. | Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15194495 |
| Cryan J et al. | FKBP, the binding protein for the immunosuppressive drug, FK-506, is not an inhibitor of protein kinase C activity. | 1991 | Biochem. Biophys. Res. Commun. | pmid:1719972 |
| Beppu K et al. | Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells. | 2003 | Biochem. Biophys. Res. Commun. | pmid:12767900 |
| Panyi G et al. | Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes. | 1996 | Biochem. Biophys. Res. Commun. | pmid:8619842 |
| Li X et al. | Tacrolimus induces fibroblasts apoptosis and reduces epidural fibrosis by regulating miR-429 and its target of RhoE. | 2017 | Biochem. Biophys. Res. Commun. | pmid:28669722 |
| Guerini D | Calcineurin: not just a simple protein phosphatase. | 1997 | Biochem. Biophys. Res. Commun. | pmid:9199180 |
| Kim HY et al. | Tracking protein-protein interaction and localization in living cells using a high-affinity molecular binder. | 2016 | Biochem. Biophys. Res. Commun. | pmid:26820537 |
| Wang H et al. | Different roles of Loop 7 in inhibition of calcineurin. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17707777 |
| Yamamoto S et al. | A new function of isonitrile as an inhibitor of the Pdr5p multidrug ABC transporter in Saccharomyces cerevisiae. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15796929 |
| Cobbs SL and Gooch JL | NFATc is required for TGFbeta-mediated transcriptional regulation of fibronectin. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17719012 |
| Nakamura T et al. | Co-stimulation with bone morphogenetic protein-9 and FK506 induces remarkable osteoblastic differentiation in rat dedifferentiated fat cells. | 2013 | Biochem. Biophys. Res. Commun. | pmid:24064349 |
| Pancer Z et al. | cDNA cloning of a putative protochordate FK506-binding protein. | 1993 | Biochem. Biophys. Res. Commun. | pmid:7505578 |
| Wiederrecht G et al. | Isolation of a human cDNA encoding a 25 kDa FK-506 and rapamycin binding protein. | 1992 | Biochem. Biophys. Res. Commun. | pmid:1376117 |
| Arie Y et al. | Developmental changes in the regulation of calcium-dependent neurite outgrowth. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19068207 |
| Tamura K et al. | Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin. | 1994 | Biochem. Biophys. Res. Commun. | pmid:7518678 |
| Kochel I et al. | Nur77 nuclear import and its NBRE-binding activity in thymic lymphoma cells are regulated by different mechanisms sensitive to FK506 or HA1004. | 2005 | Biochem. Biophys. Res. Commun. | pmid:16051191 |
| Tanaka S et al. | Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. | 2005 | Biochem. Biophys. Res. Commun. | pmid:16055081 |
| Ocain TD et al. | A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase. | 1993 | Biochem. Biophys. Res. Commun. | pmid:7685167 |
| Asami M et al. | Detection of the FK506-FKBP-calcineurin complex by a simple binding assay. | 1993 | Biochem. Biophys. Res. Commun. | pmid:7685169 |
| Hofbauer LC et al. | Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11162519 |
| Ke H and Huai Q | Structures of calcineurin and its complexes with immunophilins-immunosuppressants. | 2003 | Biochem. Biophys. Res. Commun. | pmid:14623295 |
| Jeong JH et al. | Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23523788 |
| Leiva MC and Lyttle CR | Leukocyte chemotactic activity of FKBP and inhibition by FK506. | 1992 | Biochem. Biophys. Res. Commun. | pmid:1379802 |
| Kugimiya F et al. | Mechanism of osteogenic induction by FK506 via BMP/Smad pathways. | 2005 | Biochem. Biophys. Res. Commun. | pmid:16246307 |
| Antoni FA et al. | Inhibitory role for calcineurin in stimulus-secretion coupling revealed by FK506 and cyclosporin A in pituitary corticotrope tumor cells. | 1993 | Biochem. Biophys. Res. Commun. | pmid:7687429 |
| Denesyuk AI et al. | Comparison of conformations of cyclosporin A and macrolide FK506 fragments: localization of putative binding sites with phosphatase calcineurin. | 1993 | Biochem. Biophys. Res. Commun. | pmid:7687433 |
| Krasowska A et al. | Cell ATP level of Saccharomyces cerevisiae sensitively responds to culture growth and drug-inflicted variations in membrane integrity and PDR pump activity. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20346916 |
| Lochmüller H et al. | Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. | 1995 | Biochem. Biophys. Res. Commun. | pmid:7544122 |
| Zhou N et al. | Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20580688 |
| Davis DL and Soldin SJ | Identification of ubiquitin as an immunophilin. | 2000 | Biochem. Biophys. Res. Commun. | pmid:11032725 |
| Ishizuka T et al. | Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. | 1997 | Biochem. Biophys. Res. Commun. | pmid:9016789 |
| Marquis-Omer D et al. | Stabilization of the FK506 binding protein by ligand binding. | 1991 | Biochem. Biophys. Res. Commun. | pmid:1716886 |
| Wang Y et al. | FK506 protects heart function via increasing autophagy after myocardial infarction in mice. | 2017 | Biochem. Biophys. Res. Commun. | pmid:28965948 |
| Sata M and Walsh K | Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: implication for accelerated vasculopathy by immunosuppressive therapy. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10491310 |
| Hempen CM et al. | Hematocrit-independent recovery of immunosuppressants from DBS using heated flow-through desorption. | 2015 | Bioanalysis | pmid:26327182 |
| Taillon MP et al. | Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC-MS/MS. | 2011 | Bioanalysis | pmid:21649497 |
| Yuan C et al. | A simple and robust LC-MS/MS method for measuring sirolimus and everolimus in whole blood. | 2014 | Bioanalysis | pmid:25077621 |
| Koster RA et al. | Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems. | 2017 | Bioanalysis | pmid:28300419 |
| Koster RA et al. | The performance of five different dried blood spot cards for the analysis of six immunosuppressants. | 2015 | Bioanalysis | pmid:26045003 |
| Zhang CW et al. | [Establishment of a real-time PCR assay for simultaneously detecting human BKV and CMV DNA and its application in renal transplantation recipients]. | 2013 | Bing Du Xue Bao | pmid:23895006 |
| Holler E | Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment. | 2007 | Best Pract Res Clin Haematol | pmid:17448962 |
| de Mare-Bredemeijer EL and Metselaar HJ | Optimization of the use of Calcineurin inhibitors in liver transplantation. | 2012 | Best Pract Res Clin Gastroenterol | pmid:22482528 |
| Koutroubakis IE | The patient with persistent perianal fistulae. | 2007 | Best Pract Res Clin Gastroenterol | pmid:17544114 |
| Xie ZQ et al. | [Effect of topical tacrolimus ointment on expression of Toll-like receptors 2 and 4 in lesional atopic dermatitis skin]. | 2006 | Beijing Da Xue Xue Bao | pmid:16892151 |
| Sun W et al. | [Association factors analysis of diarrhea in patients receiving kidney transplantation]. | 2013 | Beijing Da Xue Xue Bao | pmid:24136278 |
| Xie ZQ et al. | [Expression of nuclear factor kappaB and the effect of topical tacrolimus ointment on lesional atopic dermatitis skin]. | 2004 | Beijing Da Xue Xue Bao | pmid:15489928 |
| Taglialatela G et al. | Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. | 2009 | Behav. Brain Res. | pmid:19162087 |
| Clift DE et al. | Effects of embryonic cyclosporine exposures on brain development and behavior. | 2015 | Behav. Brain Res. | pmid:25591474 |
| Arora RB et al. | FK506 attenuates intracerebroventricular streptozotocin-induced neurotoxicity in rats. | 2013 | Behav Pharmacol | pmid:26057771 |
| Homayoun H et al. | The effects of FK506 on the development and expression of morphine tolerance and dependence in mice. | 2003 | Behav Pharmacol | pmid:12658072 |
| Wu Q et al. | Heterogeneity of radiological spectrum in tacrolimus-associated encephalopathy after lung transplantation. | 2014 | Behav Neurol | pmid:24970980 |
| Cumming DV et al. | Pharmacological preconditioning of primary rat cardiac myocytes by FK506. | 1996 Sep-Oct | Basic Res. Cardiol. | pmid:8922254 |
| Ikeda Y et al. | Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation. | 2006 | Basic Res. Cardiol. | pmid:16619106 |
| Kise H et al. | Cardiac and haemodynamic effects of tacrolimus in the halothane-anaesthetized dog. | 2010 | Basic Clin. Pharmacol. Toxicol. | pmid:19912168 |
| Zhang H et al. | Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling. | 2018 | Basic Clin. Pharmacol. Toxicol. | pmid:28945011 |
| Han N et al. | Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. | 2014 | Basic Clin. Pharmacol. Toxicol. | pmid:24238261 |
| Huang F et al. | Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study. | 2018 | Basic Clin. Pharmacol. Toxicol. | pmid:29427400 |
| Quteineh L et al. | Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients. | 2008 | Basic Clin. Pharmacol. Toxicol. | pmid:19067682 |
| Kagaya H et al. | Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation. | 2010 | Basic Clin. Pharmacol. Toxicol. | pmid:20136638 |
| Kim IW et al. | Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients. | 2012 | Basic Clin. Pharmacol. Toxicol. | pmid:22469198 |
| Panahi Y et al. | Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study. | 2009 | Basic Clin. Pharmacol. Toxicol. | pmid:19143752 |
| Velickovic-Radovanovic RM et al. | Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy. | 2010 | Basic Clin. Pharmacol. Toxicol. | pmid:20102364 |
| Hisamura F et al. | Protective effect of green tea extract and tea polyphenols against FK506-induced cytotoxicity in renal cells. | 2006 | Basic Clin. Pharmacol. Toxicol. | pmid:16445594 |
| Hu R et al. | CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation. | 2018 | Basic Clin. Pharmacol. Toxicol. | pmid:29603629 |
| Ekici Günay N et al. | Administration of Extract (EGb761) Alone and in Combination with FK506 Promotes Liver Regeneration in a Rat Model of Partial Hepatectomy. | 2018 | Balkan Med J | pmid:29553465 |
| Gates T | Atopic dermatitis: diagnosis, treatment, and aeromedical implications. | 2007 | Aviat Space Environ Med | pmid:17225479 |
| Nakagaki T et al. | FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice. | 2013 | Autophagy | pmid:23800841 |
| Matsumura C et al. | Differential effects of FK506 and cyclosporin A on catecholamine release from bovine adrenal chromaffin cells. | 2004 | Auton Autacoid Pharmacol | pmid:15541012 |
| Shinkura N et al. | Autoantibodies to FK506 binding protein 12 (FKBP12) in autoimmune diseases. | 1999 | Autoimmunity | pmid:10433096 |
| Maalej A et al. | Evidence of association between FKBP1B and thyroid autoimmune disorders in a large Tunisian family. | 2004 | Autoimmunity | pmid:15497458 |
| Thomson AW et al. | ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. | 1993 | Autoimmunity | pmid:7505632 |
| Lemster B et al. | Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. | 1994 | Autoimmunity | pmid:7539635 |
| Thomson AW and Starzl TE | FK 506 and autoimmune disease: perspective and prospects. | 1992 | Autoimmunity | pmid:1382646 |
| Mochizuki M and Kawashima H | Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. | 1990 | Autoimmunity | pmid:1717007 |
| Ni M et al. | FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis. | 1990 | Autoimmunity | pmid:1717008 |
| Hannah J et al. | Tacrolimus use in lupus nephritis: A systematic review and meta-analysis. | 2016 | Autoimmun Rev | pmid:26427983 |
| Dall'Olio E et al. | Erosive pustular dermatosis of the leg: long-term control with topical tacrolimus. | 2011 | Australas. J. Dermatol. | pmid:21332681 |
| Shamsudin N et al. | Objective assessment of vitiligo with a computerised digital imaging analysis system. | 2015 | Australas. J. Dermatol. | pmid:25367709 |
| Dar NR and Rao SU | Facial lichen nitidus actinicus. | 2012 | Australas. J. Dermatol. | pmid:22571575 |
| Milcic D and Nikolic M | Clinical effects of topical pimecrolimus in a patient with Fox-Fordyce disease. | 2012 | Australas. J. Dermatol. | pmid:22571582 |
| Lee FJ et al. | Poor efficacy of oral tacrolimus in the treatment of severe generalized atopic eczema in adults: a small retrospective case series. | 2012 | Australas. J. Dermatol. | pmid:23157781 |
| Zirbs M et al. | Demodicidosis associated with psoriasis therapy--two case reports. | 2013 | Australas. J. Dermatol. | pmid:23905976 |
| Patterson C and Coutts I | Granuloma faciale successfully treated with topical tacrolimus. | 2009 | Australas. J. Dermatol. | pmid:19659988 |
| Cassis TB and Callen JP | Bupropion-induced subacute cutaneous lupus erythematosus. | 2005 | Australas. J. Dermatol. | pmid:16197429 |
| Wilson LM and Reid CM | Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment. | 2004 | Australas. J. Dermatol. | pmid:15250900 |
| Christophers E | Psoriasis: mechanisms and entry points for possible therapeutic interventions. | 1996 | Australas. J. Dermatol. | pmid:8713012 |
| Pirmez R et al. | Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus. | 2016 | Australas. J. Dermatol. | pmid:27124649 |
| Starritt E and Lee S | Erythroplasia of Queyrat of the glans penis on a background of Zoon's plasma cell balanitis. | 2008 | Australas. J. Dermatol. | pmid:18412812 |
| Black M and Marshman G | Dermatomyositis and pemphigus vulgaris: association or coincidence? | 2011 | Australas. J. Dermatol. | pmid:21605086 |
| Chung TH et al. | Topical tacrolimus (FK506) for the treatment of feline idiopathic facial dermatitis. | 2009 | Aust. Vet. J. | pmid:19796164 |
| Cooley HM et al. | Resolution of pyoderma gangrenosum using tacolimus (FK-506) | 1996 | Aust N Z J Med | pmid:8744629 |
| Grillo E et al. | Necrobiosis lipoidica. | 2014 | Aust Fam Physician | pmid:24600675 |
| Grillo E et al. | Skin rash associated with limb weakness. | 2012 | Aust Fam Physician | pmid:23210105 |
| Ichimaru N et al. | Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. | 2001 | Atherosclerosis | pmid:11583721 |
| Hamada N et al. | Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model. | 2010 | Atherosclerosis | pmid:19682688 |
| Matsumoto T et al. | Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits. | 1998 | Atherosclerosis | pmid:9699896 |
| Riba Torrecillas D et al. | [Use of topical tacrolimus and its side-effects]. | 2005 | Aten Primaria | pmid:15946616 |
| Clark K et al. | Oxidative Stress Induces Disruption of the Axon Initial Segment. | ASN Neuro | pmid:29228786 | |
| Labcharoenwongs P et al. | A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. | 2012 | Asian Pac. J. Allergy Immunol. | pmid:23156846 |
| Manuyakorn W et al. | In vitro cytokine changes after pediatric liver transplantation. | 2015 | Asian Pac. J. Allergy Immunol. | pmid:25840634 |